OncoMed Pharmaceuticals, Inc.
(NASDAQ : OMED)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.99%75.181.0%$2008.10m
AMGNAmgen, Inc. -1.75%204.831.3%$927.92m
REGNRegeneron Pharmaceuticals, Inc. 0.32%474.502.6%$804.84m
BIIBBiogen, Inc. -0.14%315.681.5%$750.52m
VRTXVertex Pharmaceuticals, Inc. 2.14%236.891.9%$576.39m
MRNAModerna, Inc. -2.23%29.800.0%$550.09m
ILMNIllumina, Inc. -0.61%274.563.5%$475.39m
ALXNAlexion Pharmaceuticals, Inc. 2.50%89.452.0%$285.63m
AAgilent Technologies, Inc. -1.02%71.931.6%$234.28m
EXASEXACT Sciences Corp. -0.57%58.1021.0%$199.53m
INCYIncyte Corp. 1.16%73.012.5%$178.79m
SGENSeattle Genetics, Inc. 2.07%117.686.1%$173.23m
BMRNBioMarin Pharmaceutical, Inc. 3.35%85.264.3%$166.27m
NVAXNovavax, Inc. -2.17%13.99114.7%$130.63m
ALNYAlnylam Pharmaceuticals, Inc. 1.99%111.008.7%$103.36m

Company Profile

OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.